Kelly Financial Services’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100
| Closed | -$2.96K | – | 836 |
|
|
2023
Q4 | $2.96K | Hold |
100
| – | – | ﹤0.01% | 539 |
|
|
2023
Q3 | $1.59K | Hold |
100
| – | – | ﹤0.01% | 570 |
|
|
2023
Q2 | $1.89K | Hold |
100
| – | – | ﹤0.01% | 555 |
|
|
2023
Q1 | $384 | Hold |
100
| – | – | ﹤0.01% | 645 |
|
|
2022
Q4 | $496 | Hold |
100
| – | – | ﹤0.01% | 606 |
|
|
2022
Q3 | $478 | Hold |
100
| – | – | ﹤0.01% | 615 |
|
|
2022
Q2 | $450 | Hold |
100
| – | – | ﹤0.01% | 609 |
|
|
2022
Q1 | $476 | Hold |
100
| – | – | ﹤0.01% | 613 |
|
|
2021
Q4 | $742 | Hold |
100
| – | – | ﹤0.01% | 599 |
|
|
2021
Q3 | $567 | Sell |
100
-559
| -85% | -$3.23K | ﹤0.01% | 594 |
|
|
2021
Q2 | $100K | Buy |
659
+559
| +559% | +$3.9K | ﹤0.01% | 387 |
|
|
2021
Q1 | $810 | Hold |
100
| – | – | ﹤0.01% | 560 |
|
|
2020
Q4 | $645 | Hold |
100
| – | – | ﹤0.01% | 533 |
|
|
2020
Q3 | $360 | Hold |
100
| – | – | ﹤0.01% | 529 |
|
|
2020
Q2 | $460 | Hold |
100
| – | – | ﹤0.01% | 534 |
|
|
2020
Q1 | $341 | Sell |
100
-220
| -69% | -$962 | ﹤0.01% | 514 |
|
|
2019
Q4 | $1.63K | Buy |
320
+220
| +220% | +$747 | ﹤0.01% | 433 |
|
|
2019
Q3 | $242 | Hold |
100
| – | – | ﹤0.01% | 509 |
|
|
2019
Q2 | $217 | Hold |
100
| – | – | ﹤0.01% | 468 |
|
|
2019
Q1 | $271 | Buy |
+100
| New | +$433 | ﹤0.01% | 457 |
|
Other funds holding IMGN
Kelly Financial Services's IMGN Position: Q1 2024 in Review
Kelly Financial Services sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 100 shares — an estimated $2.96K sold.
Kelly Financial Services first reported a position in IMGN in Q1 2019 and held it in 20 quarters. The position peaked at $100K in Q2 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Kelly Financial Services reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Kelly Financial Services sold 100 Immunogen Inc shares in Q1 2024, an estimated $2.96K.
- Kelly Financial Services first reported a position in Immunogen Inc in Q1 2019 and held it in 20 quarters.
- Kelly Financial Services's Immunogen Inc position peaked at $100K in Q2 2021.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Kelly Financial Services's 13F filing for Q1 2024, filed 17 Jul 2024.